GlassScriptPhysician profile
Fung Lam
NPI 1225186620
$859.07
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $827 · 2020: $32.50.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $249.89 | 2019 | |
| Merck Sharp & Dohme LLC | $182.65 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $132.88 | 2019 | |
| Ethicon US, LLC | $87.29 | 2019 | |
| Amgen INC. | $63.65 | 2019 | |
| Abbvie INC. | $42.56 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.87 | 2019 | |
| Coopersurgical, INC. | $22.82 | 2019 | |
| Hologic Sales and Service, LLC | $14.65 | 2020 | |
| Mallinckrodt Enterprises LLC | $14.63 | 2019 | |
| Allergan, INC. | $14.18 | 2019 |
4 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fung Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.